Texas Yale Capital Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.15M Buy
36,037
+205
+0.6% +$47.8K 0.2% 62
2026
Q1
$8.76M Buy
35,832
+2,325
+7% +$542K 0.25% 58
2025
Q4
$6.93M Sell
33,507
-1,550
-4% -$307K 0.21% 65
2025
Q3
$6.5M Buy
35,057
+5,670
+19% +$971K 0.2% 71
2025
Q2
$4.49M Buy
29,387
+705
+2% +$108K 0.15% 99
2025
Q1
$4.76M Sell
28,682
-430
-1% -$67.3K 0.2% 90
2024
Q4
$4.21M Sell
29,112
-800
-3% -$124K 0.17% 97
2024
Q3
$4.85M Sell
29,912
-595
-2% -$94.8K 0.21% 84
2024
Q2
$4.46M Sell
30,507
-485
-2% -$72.1K 0.21% 85
2024
Q1
$4.9M Sell
30,992
-275
-0.9% -$43.8K 0.22% 76
2023
Q4
$4.9M Buy
31,267
+206
+0.7% +$31.6K 0.23% 70
2023
Q3
$4.84M Sell
31,061
-630
-2% -$104K 0.22% 64
2023
Q2
$5.25M Buy
31,691
+384
+1% +$62K 0.25% 55
2023
Q1
$4.85M Sell
31,307
-397
-1% -$64.1K 0.25% 67
2022
Q4
$5.6M Buy
31,704
+84
+0.3% +$14.5K 0.32% 50
2022
Q3
$5.17M Sell
31,620
-117
-0.4% -$19.8K 0.33% 47
2022
Q2
$5.63M Buy
31,737
+176
+0.6% +$31.4K 0.36% 47
2022
Q1
$5.59M Buy
31,561
+1
+0% +$170 0.3% 65
2021
Q4
$5.4M Buy
31,560
+216
+0.7% +$35.4K 0.27% 70
2021
Q3
$5.06M Sell
31,344
-319
-1% -$54.4K 0.29% 75
2021
Q2
$5.22M Buy
31,663
+101
+0.3% +$16.7K 0.3% 70
2021
Q1
$5.19M Sell
31,562
-1,869
-6% -$302K 0.33% 63
2020
Q4
$5.26M Buy
33,431
+231
+0.7% +$34.1K 0.35% 55
2020
Q3
$4.94M Sell
33,200
-65
-0.2% -$9.62K 0.38% 56
2020
Q2
$4.68M Sell
33,265
-332
-1% -$48.4K 0.38% 58
2020
Q1
$4.41M Sell
33,597
-1,838
-5% -$261K 0.43% 46
2019
Q4
$5.17M Sell
35,435
-497
-1% -$67.4K 0.35% 55
2019
Q3
$4.65M Sell
35,932
-555
-2% -$73.1K 0.33% 57
2019
Q2
$5.08M Sell
36,487
-36,487
-50% -$5.05M 0.38% 50
2019
Q1
$10.2M Buy
72,974
+36,459
+100% +$4.88M 0.41% 47
2018
Q4
$4.71M Sell
36,515
-273
-0.7% -$38.1K 0.43% 43
2018
Q3
$5.08M Buy
36,788
+82
+0.2% +$10.9K 0.41% 44
2018
Q2
$4.45M Sell
36,706
-3,079
-8% -$384K 0.38% 44
2018
Q1
$5.1M Sell
39,785
-213
-0.5% -$28.8K 0.44% 39
2017
Q4
$5.59M Buy
39,998
+345
+0.9% +$48.1K 0.48% 38
2017
Q3
$5.16M Sell
39,653
-584
-1% -$77.4K 0.45% 42
2017
Q2
$5.32M Buy
40,237
+133
+0.3% +$17K 0.47% 37
2017
Q1
$5M Sell
40,104
-1,462
-4% -$175K 0.44% 39
2016
Q4
$4.79M Sell
41,566
-446
-1% -$51.5K 0.45% 40
2016
Q3
$4.96M Buy
42,012
+3
+0% +$364 0.48% 40
2016
Q2
$5.1M Sell
42,009
-87
-0.2% -$9.89K 0.51% 37
2016
Q1
$4.55M Sell
42,096
-1,127
-3% -$117K 0.47% 42
2015
Q4
$4.44M Buy
43,223
+1,143
+3% +$115K 0.43% 46
2015
Q3
$3.93M Sell
42,080
-936
-2% -$90.5K 0.37% 54
2015
Q2
$4.19M Sell
43,016
-5,804
-12% -$581K 0.35% 55
2015
Q1
$4.91M Sell
48,820
-11,687
-19% -$1.19M 0.4% 51
2014
Q4
$6.33M Buy
60,507
+3,673
+6% +$387K 0.55% 35
2014
Q3
$6.06M Buy
56,834
+11,856
+26% +$1.23M 0.57% 33
2014
Q2
$4.71M Buy
44,978
+753
+2% +$76.1K 0.59% 37
2014
Q1
$4.34M Sell
44,225
-792
-2% -$73.4K 0.6% 37
2013
Q4
$4.12M Buy
45,017
+3
+0% +$276 0.63% 38
2013
Q3
$3.9M Buy
45,014
+4,243
+10% +$381K 0.66% 36
2013
Q2
$3.5M Buy
+40,771
New +$3.46M 0.61% 42

Other funds holding JNJ

Texas Yale Capital Corp's JNJ Position: Q2 2026 in Review

Texas Yale Capital Corp increased its Johnson & Johnson (JNJ) stake by 0.57% in Q2 2026, buying an estimated $47.8K and bringing the position to 36,037 shares worth $9.15M. The position accounts for 0.2% of the portfolio, ranked #62.

Texas Yale Capital Corp first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.2M in Q1 2019. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Texas Yale Capital Corp held 36,037 shares of Johnson & Johnson worth $9.15M as of Q2 2026.
  • Texas Yale Capital Corp bought 205 Johnson & Johnson shares in Q2 2026, an estimated $47.8K.
  • Johnson & Johnson made up 0.2% of Texas Yale Capital Corp's portfolio in Q2 2026, its #62 holding.
  • Texas Yale Capital Corp first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Texas Yale Capital Corp's Johnson & Johnson position peaked at $10.2M in Q1 2019.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.